<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Authors describe initial characteristics, clinical course and response to treatment of 13 children, aged from eight months to nine years, with acquired aplastic <z:hpo ids='HP_0001903'>anaemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Six of the children had been exposed to products with potential <z:e sem="disease" ids="C0948168" disease_type="Disease or Syndrome" abbrv="">bone-marrow toxicity</z:e>: chloranphenicol (1), pirazolones (3) and <z:chebi fb="57" ids="24852">insecticides</z:chebi> (2) </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0001876'>Pancytopenia</z:hpo> was severe in twelve and moderate in one </plain></SENT>
<SENT sid="3" pm="."><plain>Five patients with severe aplastic <z:hpo ids='HP_0001903'>anaemia</z:hpo> were given antilymphocytic (2) or antithymocytic (3) (ATG) gammaglobulins; two of those treated with ATG responded after two and five months respectively and there was no response in the other three </plain></SENT>
<SENT sid="4" pm="."><plain>Twelve patients were given <z:chebi fb="3" ids="50113">androgen</z:chebi> treatment (oxymetholone or <z:chebi fb="0" ids="7466">nandrolone</z:chebi> <z:chebi fb="0" ids="27689">decanoate</z:chebi>): four, two of whom previously had received ATG, followed a favorable course </plain></SENT>
<SENT sid="5" pm="."><plain>None of the severe initial pancytopenic patients responded to <z:chebi fb="3" ids="50113">androgen</z:chebi> single agent treatment </plain></SENT>
<SENT sid="6" pm="."><plain>No marrow transplant was performed in any of the children </plain></SENT>
<SENT sid="7" pm="."><plain>Eight of the thirteen patients died one to 37 months after <z:hpo ids='HP_0003674'>onset</z:hpo> (median, 6 months) and five (38%) are alive after 21 months to 10 years, corresponding to two patients with moderate and three with severe initial <z:hpo ids='HP_0001876'>pancytopenia</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Importance of an appropriate supportive treatment during initial stages of the disease and the probable efficacy or immunosupressive treatment in certain patients must be underlined </plain></SENT>
</text></document>